Daniel-Meshulam I - Search Results

1

Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor-Host Feedback Signaling.

Kamer I, Daniel-Meshulam I, Zadok O, Bab-Dinitz E, Perry G, Feniger-Barish R, Perelman M, Barshack I, Ben-Nun A, Onn A, Bar J. Kamer I, et al. Among authors: daniel meshulam i. Mol Cancer Res. 2020 Jun;18(6):926-937. doi: 10.1158/1541-7786.MCR-19-0395. Epub 2020 Mar 13. Mol Cancer Res. 2020. PMID: 32169890

2

Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling.

Kamer I, Steuerman Y, Daniel-Meshulam I, Perry G, Izraeli S, Perelman M, Golan N, Simansky D, Barshack I, Ben Nun A, Gottfried T, Onn A, Gat-Viks I, Bar J. Kamer I, et al. Among authors: daniel meshulam i. Transl Lung Cancer Res. 2020 Jun;9(3):682-692. doi: 10.21037/tlcr-19-477. Transl Lung Cancer Res. 2020. PMID: 32676330 Free PMC article.

3

Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.

Shiran I, Heller E, Jessel S, Kamer I, Daniel-Meshulam I, Navon R, Urban D, Onn A, Bar J. Shiran I, et al. Among authors: daniel meshulam i. Clin Lung Cancer. 2017 May;18(3):316-323.e1. doi: 10.1016/j.cllc.2017.01.009. Epub 2017 Feb 2. Clin Lung Cancer. 2017. PMID: 28237243

4

Immunotherapy response modeling by ex-vivo organ culture for lung cancer.

Kamer I, Bab-Dinitz E, Zadok O, Ofek E, Gottfried T, Daniel-Meshulam I, Hout-Siloni G, Ben Nun A, Barshack I, Onn A, Bar J. Kamer I, et al. Among authors: daniel meshulam i. Cancer Immunol Immunother. 2021 Aug;70(8):2223-2234. doi: 10.1007/s00262-020-02828-w. Epub 2021 Jan 23. Cancer Immunol Immunother. 2021. PMID: 33484295 Free PMC article.

5

Mesencephalic astrocyte-derived neurotrophic factor is secreted from interferon-γ-activated tumor cells through ER calcium depletion.

Peled M, Bar-Lev TH, Talalai E, Aspitz HZ, Daniel-Meshulam I, Bar J, Kamer I, Ofek E, Mor A, Onn A. Peled M, et al. Among authors: daniel meshulam i. PLoS One. 2021 Apr 23;16(4):e0250178. doi: 10.1371/journal.pone.0250178. eCollection 2021. PLoS One. 2021. PMID: 33891607 Free PMC article.

6

Enhanced antitumor activity mediated by human 4-1BB-engineered T cells.

Daniel-Meshulam I, Horovitz-Fried M, Cohen CJ. Daniel-Meshulam I, et al. Int J Cancer. 2013 Dec 15;133(12):2903-13. doi: 10.1002/ijc.28320. Epub 2013 Jul 16. Int J Cancer. 2013. PMID: 23754772

7

How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer.

Daniel-Meshulam I, Ya'akobi S, Ankri C, Cohen CJ. Daniel-Meshulam I, et al. Front Immunol. 2012 Jul 6;3:186. doi: 10.3389/fimmu.2012.00186. eCollection 2012. Front Immunol. 2012. PMID: 22783259 Free PMC article.

8

Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit.

Haberman Y, Kamer I, Amir A, Goldenberg S, Efroni G, Daniel-Meshulam I, Lobachov A, Daher S, Hadar R, Gantz-Sorotsky H, Urban D, Braun T, Bar J. Haberman Y, et al. Among authors: daniel meshulam i. Sci Rep. 2023 Feb 3;13(1):2007. doi: 10.1038/s41598-023-29136-4. Sci Rep. 2023. PMID: 36737654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters